iCAD Inc (ICAD) - Financial and Strategic SWOT Analysis Review

November 2021 | 55 pages | ID: IC3BAD8920D3EN
GlobalData

Abstracts

iCAD Inc (ICAD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

iCAD Inc (iCAD) is a medical technology company that provides advanced image analysis, radiation therapies and workflow solutions for the early disclosure and treatment of cancers. The company offers cancer detection products and solutions which include Powerlook, VeraLook and ProFound AI and magnetic resonance imaging (MRI) applications for diagnostic purposes. The company also provides Xoft System, a proprietary electronic brachytherapy platform for oncology treatment. The company uses artificial intelligence for its product development. iCAD operated primarily in the US and markets products through direct sales organization, OEM partners, distributors and resellers in the US and abroad. iCAD is headquartered in Nashua, New Hampshire, the US.

iCAD Inc Key Recent Developments

Nov 09,2021: iCAD Reports Financial Results for the Quarter Ended September 30, 2021
Oct 26,2021: iCAD to Report Third Quarter 2021 Financial Results on Tuesday, November 9
Aug 05,2021: iCAD Reports Financial Results for the Quarter Ended June 30, 2021
Jul 22,2021: iCAD to Report Second Quarter 2021 Financial Results on Thursday, August 5
Apr 29,2021: iCAD Reports Financial Results for First Quarter Ended March 31, 2021

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

iCAD Inc - Key Facts
iCAD Inc - Key Employees
iCAD Inc - Key Employee Biographies
iCAD Inc - Major Products and Services
iCAD Inc - History
iCAD Inc - Company Statement
iCAD Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
iCAD Inc - Business Description
Business Segment: Cancer Detection (Detection)
Overview
Performance
Business Segment: Cancer Therapy (Therapy)
Overview
Performance
R&D Overview
iCAD Inc - Corporate Strategy
iCAD Inc - SWOT Analysis
SWOT Analysis - Overview
iCAD Inc - Strengths
iCAD Inc - Weaknesses
iCAD Inc - Opportunities
iCAD Inc - Threats
iCAD Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

iCAD Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
iCAD Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
iCAD Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Nov 09, 2021: iCAD Reports Financial Results for the Quarter Ended September 30, 2021
Oct 26, 2021: iCAD to Report Third Quarter 2021 Financial Results on Tuesday, November
Aug 05, 2021: iCAD Reports Financial Results for the Quarter Ended June 30, 2021
Jul 22, 2021: iCAD to Report Second Quarter 2021 Financial Results on Thursday, August
Apr 29, 2021: iCAD Reports Financial Results for First Quarter Ended March 31, 2021
Apr 20, 2021: iCAD to Report First Quarter 2021 Financial Results on Wednesday, April
Apr 05, 2021: iCAD Announces Estimated Q1 Revenues and Upcoming CFO Transition
Mar 03, 2021: iCAD to Participate in the Cowen 41st Annual Health Care Conference
Feb 24, 2021: iCAD reports financial results for fourth quarter and year ended December 31, 2020
Feb 18, 2021: iCAD to Report Fourth Quarter 2020 Financial Results on Wednesday, February

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

iCAD Inc, Key Facts
iCAD Inc, Key Employees
iCAD Inc, Key Employee Biographies
iCAD Inc, Major Products and Services
iCAD Inc, History
iCAD Inc, Other Locations
iCAD Inc, Subsidiaries
iCAD Inc, Key Competitors
iCAD Inc, Ratios based on current share price
iCAD Inc, Annual Ratios
iCAD Inc, Annual Ratios (Cont...1)
iCAD Inc, Annual Ratios (Cont...2)
iCAD Inc, Interim Ratios
iCAD Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
iCAD Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
iCAD Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

iCAD Inc, Performance Chart (2016 - 2020)
iCAD Inc, Ratio Charts
iCAD Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
iCAD Inc, Medical Equipment, Deals by Type, 2015 to YTD 2021